Intervention Review

Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses

  1. Ravindra B Belgamwar1,*,
  2. Mark Fenton2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 APR 2005

Assessed as up-to-date: 17 FEB 2005

DOI: 10.1002/14651858.CD003729.pub2

How to Cite

Belgamwar RB, Fenton M. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003729. DOI: 10.1002/14651858.CD003729.pub2.

Author Information

  1. 1

    Lymebrook Mental Health Centre, Newcastle Under Lyme, Staffordshire, UK

  2. 2

    James Lind Initiative, Database of Uncertainties about the Effects of Treatments (DUETs), Oxford, UK

*Ravindra B Belgamwar, Lymebrook Mental Health Centre, Bradwell Hospital Site, Newcastle Under Lyme, Staffordshire, ST5 4LD, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 APR 2005


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.